TDI-11055 is an orally available inhibitor of chromatin reader 11-19 leukemia (ENL) that works by blocking the interaction of its YEATS domain with acylated histones. TDI-11055 can be used to study acute myeloid leukemia (AML).
Molecular Weight:
388.47
Purity:
98.48%
Formula:
C22H24N6O
Target:
Endogenous Metabolite
T87946
* VAT and and shipping costs not included. Errors and price changes excepted